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Summary
The spinal muscular atrophy (SMA) gene product SMN forms with gem-associated protein 2–8 (Gemin2–8) and unrip (also known as
STRAP) the ubiquitous survival motor neuron (SMN) complex, which is required for the assembly of spliceosomal small nuclear
ribonucleoproteins (snRNPs), their nuclear import and their localization to subnuclear domain Cajal bodies (CBs). The concentration of
the SMN complex and snRNPs in CBs is reduced upon SMN deficiency in SMA cells. Subcellular localization of the SMN complex is
regulated in a phosphorylation-dependent manner and the precise mechanisms remain poorly understood. Using co-immunoprecipitation
in HeLa cell extracts and in vitro protein binding assays, we show here that the SMN complex and its component Gemin8 interact
directly with protein phosphatase PP1c. Overexpression of Gemin8 in cells increases the number of CBs and results in targeting of PP1c
to CBs. Moreover, depletion of PP1c by RNA interference enhances the localization of the SMN complex and snRNPs to CBs.
Consequently, the interaction between SMN and Gemin8 increases in cytoplasmic and nuclear extracts of PP1c-depleted cells. Two-
dimensional protein gel electrophoresis revealed that SMN is hyperphosphorylated in nuclear extracts of PP1c-depleted cells and
expression of PP1c restores these isoforms. Notably, SMN deficiency in SMA leads to the aberrant subcellular localization of Gemin8
and PP1c in the atrophic skeletal muscles, suggesting that the function of PP1c is likely to be affected in disease. Our findings reveal a
role of PP1c in the formation of the SMN complex and the maintenance of CB integrity. Finally, we propose Gemin8 interaction with
PP1c as a target for therapeutic intervention in SMA.
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Introduction
The mammalian cell nucleus is organized into distinct
compartments (Mao et al., 2011) and the Cajal body (CB) is one
of these entities (Morris, 2008). Most cells contain two to four CBs
that are identified by the protein marker coilin (Rasˇka et al., 1991).
Coilin has been conserved in evolution, and various studies suggest
that coilin and CBs are not essential in fruit fly and mice, whereas
they are in developing zebrafish embryos (Strzelecka et al., 2010).
CBs are prominent in cancer cells and neurons (Lafarga et al.,
2009). They are highly dynamic subnuclear domains enriched in
many different ribonucleoproteins (RNPs), such as spliceosomal
small nuclear RNPs (snRNPs), small nucleolar RNPs (snoRNPs),
RNA polymerases, histone mRNA processing factors and
telomerase (Cioce and Lamond, 2005; Gall, 2000; Matera et al.,
2007).
The biogenesis of snRNPs involves cytoplasmic and nuclear
phases. Synthesis starts with the transcription of a small nuclear
RNA (snRNA) precursor and CB targeting to associate with the
nuclear export complex (Suzuki et al., 2010). In the cytoplasm,
survival motor neuron (SMN) complex assembles the snRNAs
with common Sm core proteins into core snRNPs. Following
nuclear import, core snRNPs are targeted to CBs for additional
maturation and processing steps resulting in the production of
mature snRNPs for splicing in the nucleoplasm or for storage in
speckles. CBs have also been reported to increase assembly and
recycling of snRNPs after splicing (Nesic et al., 2004; Klingauf
et al., 2006; Stanek et al., 2008). The SMN complex could also
operate in these processes (Pellizzoni et al., 1998).
The ubiquitous SMN complex that includes SMN, gem-
associated protein 2–8 (Gemin2–8) and unrip (also known as
serine-threonine kinase receptor-associated protein; STRAP)
(Pellizzoni, 2007), localizes to the cytoplasm and the nucleus,
where it concentrates in CBs (Liu and Dreyfuss, 1996; Carvahlo
et al., 1999). SMN protein plays a central role in spinal
muscular atrophy (SMA), the most common human genetic
neurodegenerative disorder of infancy (Lefebvre et al., 1995).
Alterations of the SMN1 gene cause SMN protein deficiency
leading to degeneration of spinal motor neurons (MNs). This
selective vulnerability remains elusive (Burghes and Beattie,
2009). Disease severity correlates with residual levels of SMN and
abundance of CBs (Frugier et al., 2000; Lefebvre et al., 1997;
Renvoise´ et al., 2009). SMN1 is a conserved gene essential in
snRNP biogenesis and thus, in splicing (Schmid and DiDonato,
2007; Zhang et al., 2008). Studies in animal models show that
mature snRNPs could rescue developmental defects, and indicate
that snRNP production is crucial in SMA disease (Winkler et al.,
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2005). However, other SMN functions might contribute to disease
severity (Rossoll and Bassell, 2007; Hubers et al., 2011).
The severity of MN diseases correlates with a deficiency of
SMN in the nucleus (Turner et al., 2009). The precise nuclear
function of SMN is unknown. Nuclear import of the SMN
complex depends on snRNPs (Narayanan et al., 2004) and
targeting to CBs on its interaction with WD40 encoding RNA
antisense to p53 (WRAP53; also known as telomerase Cajal body
protein 1), a factor involved in CB recruitment of small CB-
specific RNAs (Mahmoudi et al., 2010). SMN has also been
reported to form a different type of nuclear body designated a
‘gem’ for Gemini of CBs (Liu and Dreyfuss, 1996). Gems
contain the components of the SMN complex and lack coilin and
snRNPs. Depletion of SMN disrupts CBs and gems, whereas
coilin depletion disrupts CBs and forms gems (Lemm et al.,
2006; Whittom et al., 2008). These data indicate that SMN is
required for CB formation, and gems form when snRNP
metabolism is disturbed. Thus, gems are thought to be storage
sites. The tethering reaction of SMN has been reconstituted in
cells, showing de novo CB formation as a non-linear assembly
process triggered by most components when SMN is present at
sufficient levels (Kaiser et al., 2008). However, the mechanisms
controlling the accumulation in CBs are so far not fully
understood.
Many forms of stress, stimuli or signaling pathways impact on
CB composition, size and number (Boulon et al., 2010). These
processes result in substantial changes in protein–protein
interactions influenced by post-translational modifications, such
as protein methylation (Boisvert et al., 2002; Hebert et al., 2002;
Clelland et al., 2009) and phosphorylation (Hebert, 2010). SMN
and coilin are phosphoproteins. The phosphorylation of SMN
regulates the stability of the complex (Burnett et al., 2009) and
snRNP assembly in the cytoplasm (Grimmler et al., 2004).
Hyperphosphorylation of coilin coincides with lack of CBs
during mitosis (Carmo-Fonseca et al., 1993) and SMN
preferentially interacts with the hypophosphorylated coilin that
forms CBs (Hebert et al., 2002). The nuclear protein phosphatase
PPM1G, which is not present in CBs, has been reported as
contributing to the dephosphorylation of SMN and coilin and to
their accumulation in CBs (Hearst et al., 2009; Petri et al., 2007).
Other studies on CBs have implicated phosphorylation: inhibiting
phosphatases and a phosphoserine mutation in coilin affect the
CB localization of coilin and of snRNPs (Lyon et al., 1997;
Sleeman et al., 1998). The nuclear phosphatase PP4 associates
with the SMN complex and enhances the temporal CB
localization of snRNPs (Carnegie et al., 2003). Moreover,
inhibition of PP1 has been shown to increase the number of
gems in SMA fibroblasts (Novoyatleva et al., 2008). How PP1
could regulate SMN localization is unknown.
PP1 holoenzymes regulate a wide range of cellular functions,
including transcription, pre-mRNA splicing, cell survival,
synaptic plasticity and muscle contraction (Ceulemans and
Bollen, 2004; Moorhead et al., 2007). In mammals, there are
three PP1 catalytic subunits (a, b/d and c), each encoded by a
different gene. The association with a regulatory (or targeting)
subunit determines the subcellular localization and substrate
specificity of the catalytic subunits (Cohen, 2002; Bollen and
Beullens, 2002). The list of approximately 180 regulatory
subunits is still growing (Bollen et al., 2010). Most targeting
proteins harbor a primary consensus PP1-binding ‘R/KVxF’
motif (Meiselbach et al., 2006) and the localization pattern of
each catalytic subunit results from the addition of many different
PP1 holoenzyme complexes. All three localize to the cytoplasm
and nucleus during interphase. PP1a and PP1c are found in the
nucleoplasm and PP1c also concentrates in nucleoli, whereas
PPP1b/d is detected throughout the nucleus with no particular
accumulation pattern (Andreassen et al., 1998). The PP1 catalytic
subunits are highly mobile and their subcellular localization
could change with the expression levels of the targeting proteins
(Trinkle-Mulcahy et al., 2001; Trinkle-Mulcahy et al., 2003).
One of the major nuclear targeting subunits of PP1a and PP1c is
the phosphatase nuclear targeting subunit PNUTS [also known as
serine/threonine-protein phosphatase 1 regulatory subunit 10
(PP1R10) and p99] that localizes to the nucleoplasm (Landsverk
et al., 2005) and can be found occasionally in CBs (Moorhead
et al., 2007). These data illustrate how dynamic and transient the
targeting of PP1 to different specific subcellular sites could be.
We report here a previously unknown mechanism of post-
translational regulation of the SMN complex by PP1c that was
determined using biochemical, proteomic, RNA interference and
immunofluorescence approaches. For in vivo immunofluorescence
experiments involving control and SMA individuals we chose the
skeletal muscle because of the very specific cytoplasmic
organization. We examined the proteins co-immunopurified with
SMN proteins and focused on a new interaction with PP1c. We
identified Gemin8, a component of the SMN complex, as a PP1-
binding protein targeting PP1c to CBs. We show that modulating
the expression levels of PP1c impact on the subnuclear
organization. Our results support the conclusion that PP1c could
regulate SMN complex formation and localization to CBs.
Results
Proteomics study of the N-terminal region of SMN
We previously produced SMN deletion mutants in order to gain
insight into its subnuclear localization in mammalian cells
(Renvoise´ et al., 2006). A diagram of the domains used in the
present study for fluorescent fusion proteins is shown in Fig. 1A.
The fragment containing the lysine-rich region [amino acids (aa)
71–83] and Tudor domain (aa 91–151) produced a fusion protein
GFP–SMN472D5 (hereafter referred to as GFP–472D5) that
localizes to the nucleoplasm and CBs. Introduction of mutations
in the lysine-rich region of GFP–472D5 abolishes the localization
in CBs. We expressed the N-terminal region of SMN as a GFP
fusion protein (GFP–N86; 86 first aa) and performed
immunoprecipitation experiments with anti-GFP antibody to
identify new interaction partners of SMN (Fig. 1B,C). In co-
immunoprecipitated proteins, we observed a major band of
approximately 40 kDa corresponding to the apparent mass of
GFP–N86 (Fig. 1C). The band was cut, digested and analysed by
mass spectrometry (MS). Peptides from GFP–N86 and from
protein phosphatase PP1c, as a candidate partner of expected
mass, were detected (supplementary material Fig. S1). We sought
to determine the relationship between PP1c and SMN because
SMN complex localization and function are regulated by protein
phosphorylation.
Co-immunoprecipitation of PP1c with the SMN complex
To test the association of PP1c with SMN, we expressed
GFP–472D5, GFP–N86 and GFP–N86M2 fusion proteins and
performed co-immunoprecipitation experiments (Fig. 1D).
Immunoblot analyses revealed that PP1c was co-
immunoprecipitated with GFP–472D5 and GFP–N86. We
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found little if any interaction between PP1c and GFP–N86M2, a
fusion protein in which the lysine residues are mutated (Renvoise´
et al., 2006). This mutation disrupts a minor self-interacting motif
of SMN that could regulate stability and CB localization of
the SMN complex (Morse et al., 2007). Interaction between
endogenous SMN and PP1c proteins appeared to be less efficient
(data not shown) than between GFP–SMN and PP1c (Fig. 1E),
suggesting that either the anti-SMN antibody masks the
interaction site or a third component mediates the interaction
between them.
Direct interaction of PP1c with SMN complex and its
component Gemin8
A pull-down assay was used to demonstrate direct interaction
between PP1c and the SMN complex (Fig. 2). Anti-SMN
antibody 4B3 allowed us to purify the SMN complex from
HeLa cell lysates under stringent conditions in order to remove
Fig. 1. Interaction of SMN and PP1c assayed by co-
immunoprecipitation. (A) Schematic representation of SMN (aa 1–294) and
mutants fused to eGFP at the N-terminus (Renvoise´ et al., 2006). SMN is
depicted with the Lys-rich, Tudor, Pro-rich, YG-box and exon7-encoded
domains. (B) Flow-chart of the immunopurification procedure.
(C) Immunoprecipitations (IPs) were performed with negative control mouse
immunoglobulins (IP Control) or anti-GFP (IP-GFP) antibody and with
extracts from COS cells expressing eGFP-tagged N86. Bound proteins were
separated by SDS-PAGE and visualized with silver staining. An arrow
indicates a 40-kDa band. The asterisk indicates the expected position of the
SMN complex component Gemin8. (D) IPs were performed with extracts
from COS cells stably expressing eGFP-tagged 472D5, N86 or double mutant
N86M2, respectively. Bound proteins were analysed by immunoblotting with
anti-PP1c antibodies. The anti-GFP incubation served as a loading control.
(E) Bound proteins after IP of GFP–SMN were analysed for PP1c and
endogenous SMN. The association of PP1c with the fusion proteins requires
the Lys-rich domain of SMN. IgGh and IgGl are the immunoglobulin heavy
and light chains, respectively.
Fig. 2. Direct interaction of PP1c with the SMN complex and its
component Gemin8. (A) HeLa cell lysate was immunoprecipitated with
negative control (IP Control) or anti-SMN antibody (IP SMN). Proteins were
eluted, resolved by SDS-PAGE and analysed by silver staining.
(B) Immunoprecipitated proteins shown in A were incubated with purified
E. coli recombinant His-tagged PP1c. Bound proteins were analysed by
immunoblotting. (C) GST and GST–Gemin8 fusion proteins were purified,
separated by SDS-PAGE and analysed by Coomassie staining. (D) GST
fusion proteins shown in C were incubated with purified His-tagged PP1c.
Bound proteins were analysed by immunoblotting. PP1c interacts directly
with Gemin8. (E) In situ PLA detection of the interaction between
endogenous proteins in HeLa cells with anti-Gemin8 and anti-PP1c
antibodies. As a control, one of the primary antibodies was omitted. Scale bar:
3 mm. (F) Co-IP of the endogenous proteins with anti-Gemin8 antibody and
HeLa cell extracts were analysed by immunoblotting with anti-PP1c and anti-
SMN antibodies. The asterisks indicate the immunoglobulins.
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any interacting proteins of weak affinity for the complex
(Fig. 2A). The antibody-immobilized complex (SMN complex)
was incubated with a purified Escherichia coli recombinant
histidine-tagged PP1c (His–PP1c). After extensive washes, the
proteins bound to the complex were eluted and tested for the
presence of His–PP1c by immunoblotting (Fig. 2B). The bound
proteins were compared with that bound to unrelated mouse
monoclonal antibody (control). The recombinant PP1c was
bound to the SMN complex. We then sought to identify the
component of the complex that mediates binding to PP1c. The
most common PP1-binding RVxF motif has the consensus
sequence [R/K]x0–1[V/I]{P}[F/W] (x represents any amino acid,
and {P} any except proline). Based on the hypothesis that SMN
might be a substrate for PP1c, the sequences of SMN and of
gemins that bind directly to SMN, namely Gemin2, 3 and 8, were
examined. The HVAW motif in Gemin8 (aa 80–83) appeared to
be a potential PP1-binding motif. Direct interaction between
Gemin8 and PP1c was tested using purified bacterial
recombinant proteins (Fig. 2C). The immobilized glutathione S-
transferase (GST)-tagged Gemin8 retained His-PP1c, whereas
the GST alone did not (Fig. 2D). Direct interaction between
Gemin8 and PP1c was further tested in fixed HeLa cells using the
in situ proximity ligation assay (in situ PLA; Fig. 2E). This
approach detects endogenous protein–protein interactions in
fixed cells using antibodies specific for each protein
(Fredriksson et al., 2002). Using in situ PLA, the Gemin8–
PP1c interaction appeared as bright dots in the cytoplasm,
nucleoplasm and CBs. Moreover, endogenous Gemin8 interacted
with PP1c and SMN in co-immunoprecipitation experiments
(Fig. 2F). Our results support the conclusion that Gemin8 is a
PP1-binding protein.
Overexpression of Gemin8 colocalizes PP1c with CB
markers
Given that PP1-binding proteins confer subcellular localization
and substrate specificity to PP1 holoenzymes, Gemin8 was
expressed as a fluorescent fusion (FP–Gemin8; Fig. 3A) and its
colocalization with SMN and PP1c was tested. FP–Gemin8
completely colocalized with SMN to the cytoplasm and nuclear
CBs (Fig. 3B), as reported (Carissimi et al., 2006). In FP–
Gemin8-expressing cells, PP1c was concentrated in numerous
nuclear bodies with the fusion, whereas it was concentrated in
nucleoli of untransfected cells and cells expressing either FP–
SMN, myc–Gemin4 or FP alone (Fig. 3C). Colocalization with
FP–Gemin8 could be due to the presence of other PP1-binding
proteins in CBs. The C-terminal region of Gemin8 including the
coiled coil domain (FP–G8DC) was deleted to reduce nuclear
body formation and we introduced mutations in the putative PP1-
binding motif (FP–G8DC3A; Fig. 3A,C). Both FP–G8DC and
FP–G8DC3A localized to the nucleoplasm and to fewer CBs. FP–
G8DC recruited PP1c into CBs, whereas FP–G8DC3A did not.
These experiments revealed that the HVAW motif of Gemin8 is
required for the localization of PP1c to CBs. Altogether, our
results support the conclusion that Gemin8 contributes to CB
localization of PP1c in mammalian cells.
To determine whether the FP–Gemin8 nuclear bodies
contained other CB constituents, colocalization with coilin (a
CB marker), Gemin3 and components of snRNPs was examined
(Fig. 4A–E). All FP–Gemin8 nuclear bodies were CBs as
indicated by complete colocalization with coilin. They were
also enriched in Gemin3 and snRNP-specific markers, such as the
Fig. 3. Targeting of PP1c to Cajal bodies in cells overexpressing Gemin8.
(A) Schematic representation of Gemin8 (aa 1–242) and mutants fused to
destabilized YFP (FP) at the N-terminus. Gemin8 is depicted with the putative
PP1-binding motif HVAW and a self-association coiled-coil domain (accession
number Q9NWZ8). The expressed fusion proteins were assayed in total cell
lysates by immunoblotting with anti-FP antibody. The asterisk indicates an
unspecific protein band from HeLa cells. (B) Immunofluorescence experiments
were performed in HeLa cells expressing FP–Gemin8 fusion protein with anti-
SMN antibody. FP–Gemin8 colocalizes with SMN in the cytoplasm and
nuclear bodies as shown in yellow (merged images) in low- and high-
expressing cells. (C) FP–Gemin8, FP–G8DC, FP–G8DC3A, FP–SMN, myc–
Gemin4 and FP alone were expressed and analysed by immunofluorescence
with anti-PP1c antibody. Overexpression of FP–Gemin8 changes the
localization of PP1c from nucleoli to Gemin8-expressing nuclear bodies in a
manner dependent on the HVAW motif of Gemin8. Arrowheads point to
untransfected cells and arrows to cells expressing fusions. Scale bar:
3 mm.
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trimethylguanosine (TMG)-capped snRNAs (molecular signature
for the nuclear import of snRNAs), snRNP Sm core protein
SmD3 (one of the seven Sm proteins common to all snRNPs
except U6 snRNP) and U1-specific 70 kDa protein. The
localization of the abundant splicing factor SC35 that is a
marker of speckles (Spector, 1993) and does not concentrate in
CBs was investigated. Fig. 4F showed that SC35 staining occurs
in speckles and not in CBs of FP–Gemin8-expressing cells,
supporting the conclusion that the accumulation of PP1c in CBs
is specific. Our results demonstrated that Gemin8 could form
CBs, which contain SMN complex, snRNPs and PP1c.
Depletion of PP1c enhances the accumulation of SMN
complex and snRNPs in CBs
To determine whether there might be a functional link between
PP1c and SMN targeting to CBs, RNA interference (RNAi)
knockdown experiments were performed using three distinct
PP1c-specific small interfering RNA (siRNA) duplexes (Fig. 5).
We first tested the protein levels of total lysates of HeLa cells
transfected with either a negative control firefly luciferase (Gl2)
or PP1c siRNAs (si#5, si#6 and si#8) by immunoblotting. The
PP1c-specific siRNAs reduced PP1c protein levels by ,65%
(Fig. 5A). SMN complex levels remained the same, indicating
the specificity of the siRNAs used to reduce PP1c levels. As a
control, the overall phosphorylation profile of total protein
lysates was examined (Fig. 5A, furthest right panel). There were
no major differences between PP1c-depleted cell lysates and
controls, indicating that PP1 holoenzymes have overlapping
substrates. The localization of SMN in siRNA-treated cells was
then examined by immunofluorescence experiments (Fig. 5B).
Depletion of PP1c (as shown by the reduced PP1c staining) led to
a significant (P,0.001) increase in the proportion of cells with
more SMN nuclear bodies than control cells (Fig. 5B,C). There
was a three- to fourfold increase in the proportion of cells with
more than five nuclear bodies. All three PP1c siRNAs confirmed
the formation of CBs upon depletion of PP1c (Fig. 5C).
Colocalization experiments with coilin and CB components,
including Gemin3, Gemin8 and snRNP-specific markers, all had
Fig. 4. Overexpressed Gemin8 colocalizes PP1c in CBs with the
SMN complex and snRNPs. FP–Gemin8 was expressed in HeLa
cells and analysed by immunofluorescence with (A) anti-coilin (CB
marker), (B) anti-Gemin3, a component of the SMN complex,
(C) anti-TMG-capped snRNA, (D) anti-SmD3 common core snRNP
protein and (E) anti-U1 snRNP-specific 70 kDa protein antibodies.
Colocalization results in yellow signals (in the merged images).
(F) The distribution of the splicing factor SC35 remains in the
speckles (in red), indicating the specificity of the overlapping
localizations in yellow observed above. The microscope was focused
on nuclear foci. Scale bar: 3 mm.
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similar results (Fig. 6A–F). These data indicate that depletion of
PP1c increases CB numbers and has no adverse effect on their
composition.
In the nucleus, SMN is localized with coilin in CBs and in
gems, which lack coilin and snRNPs (Liu and Dreyfuss, 1996).
To examine whether SMN localizes to either type of nuclear
body in PP1c-depleted cells, triple immunolabelling experiments
were performed with PP1c, SMN and coilin antibodies (Fig. 7A–
D). In control Gl2 siRNA-treated cells SMN localized to both
gems and CBs (Fig. 7A), whereas depletion of PP1c led to
complete localization of SMN to CBs (Fig. 7B). To demonstrate
the specificity of the effects observed above, FP–PP1c was
expressed using a cDNA resistant to siRNA#5 (Fig. 7C). FP–
PP1c expression restored the localization of SMN to gems and
CBs, whereas FP alone did not (Fig. 7D). Statistical analyses
confirmed these results (Fig. 7E). The increased number of CBs
observed in PP1c-depleted cells was significantly (P,0.001)
reduced in rescue experiments, indicating that the siRNA-
mediated effects are specific of PP1c. Our results support the
conclusion that localization of SMN complex in either CBs or
gems involves PP1c.
Depletion of PP1c changes the post-translational
modification pattern of SMN
To attempt to understand how PP1c is involved in CB
localization of the SMN complex as demonstrated above, we
sought to determine whether depletion of PP1c might influence
the phosphorylation status of SMN. To test the
hyperphosphorylation hypothesis, SMN immunoblotting of two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE) gels
was performed. As a control, protein levels in siRNA-transfected
cell lysates were examined (Fig. 7F). The PP1c siRNA led to
PP1c reduction when compared with Gl2 siRNA (control RNAi).
Transfection of PP1c siRNA#5 alone or with a FP–PP1c
expression plasmid resistant to the siRNA#5 did not reduce
either PP1a (PP1 catalytic subunit alpha) or SMN levels, again
indicating the specificity of this approach. The post-translational
modification patterns of SMN from nuclear extracts of
transfected cells were compared and relative signal intensities
were measured (Fig. 7G,H). A complex pattern of numerous
SMN isoforms was detected in control conditions as reported
previously (Grimmler et al., 2004). Examination of SMN
isoforms from PP1c-depleted cell extracts revealed striking
differences. First, SMN phosphorylation increased upon
depletion of PP1c as indicated by the accumulation of more
acidic isoforms (section 1), whereas expression of FP–PP1c
reduced them. Second, the spots at pH 6.8 (section 2) and pH 8.5
(section 3) that were reduced upon PP1c depletion (Fig. 7G,
arrows) were also rescued by FP–PP1c. Third, a basic isoform at
pH 9.2 (section 4, arrowhead) accumulated in PP1c-depleted
extracts, whereas FP–PP1c caused it to disappear, and a slightly
less basic spot to form. Finally, overall populations of spots from
section 2–4 were partially rescued by FP–PP1c. Our results
support the conclusion that PP1c regulates changes in the post-
translational modification pattern of SMN.
Depletion of PP1c results in an increased association of
SMN and Gemins
We tested the possibility that the increased number of CBs
demonstrated above in PP1c-depleted cells might correlate with
accumulation of the SMN complex in the nucleus. Cytosolic and
nuclear fractions were prepared from HeLa cells transfected with
either Gl2 or PP1c siRNAs and the distribution of the SMN
complex was monitored by immunoblotting (Fig. 8A). It was not
possible to probe for Gemin5, -6 and -7 because of the limited
affinities of commercial antibodies. Gemin8 and unrip were
Fig. 5. Depletion of PP1c enhances the accumulation of SMN nuclear
bodies. HeLa cells were transfected with negative control Gl2 (GL2; firefly
luciferase) or three different PP1c siRNAs (#5, #6 and #8). (A) Cell lysates
were analysed by immunoblotting using antibodies against components of the
SMN complex. Incubation of a-tubulin served as a loading control. siRNA #5,
#6 and #8 reduced the levels of PP1c by 69, 64 and 64%, respectively (n55
experiments). The immunoblot in the right panel shows that lowering PP1c
levels (siRNA#5) had no major effect on the overall phosphoserine profile.
(B) Double-labeling immunofluorescence experiments were performed using
anti-PP1c (red) and anti-SMN antibodies (green). The arrows point to
silenced cells. The asterisk indicates an unsilenced cell. The microscope was
focused on the nuclear foci. Scale bar: 3 mm. (C) Statistical analyses of SMN
nuclear bodies in silenced cells (n.1000 cells). Error bars indicate the
standard error of the mean (s.e.m.); ***P,0.001 (Student’s t-test).
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predominantly cytosolic as reported (Carissimi et al., 2005;
Carissimi et al., 2006; Grimmler et al., 2005). There was no
major change in the nucleocytoplasmic distribution of the SMN
complex, indicating that PP1c is not involved in this process.
Given the role of phosphorylation in protein–protein
interactions, we tested whether PP1c might regulate the
association of the Gemins with SMN. To this effect, cytosolic
and nuclear fractions were immunoprecipitated using anti-SMN
antibodies, and co-immunoprecipitated proteins were analysed
by immunoblotting (Fig. 8B–D). In SMN complexes from the
cytosol of PP1c-depleted cells, Gemin4 and -8 and unrip were
significantly (P,0.042) increased relative to SMN, whereas
Gemin2 and -3 were not (Fig. 8C). Similar changes were found
when the nuclear SMN complexes were examined (Fig. 8D).
This indicated no major change in the association of SMN–
Gemin2–Gemin3 subcomplex, whereas the association of the
peripheral Gemins changed. As described previously (Carissimi
et al., 2006; Charroux et al., 2000; Otter et al., 2007), SMN
interacts directly with Gemin8, and Gemin3 with Gemin4. Our
results support the conclusion that PP1c regulates these
interactions.
PP1c and Gemin8 colocalize in the cytoplasm of skeletal
muscles
As a first approach to understand the in vivo physiological
relevance of the interaction between Gemin8 and PP1c
demonstrated here, we sought to determine their colocalization
in mammalian tissue sections. The skeletal muscle was chosen
for its specific subcellular organization and localization of the
SMN complex at the Z-discs of mouse myofibrils (Walker et al.,
2008). Using the Prestige anti-Gemin8 antibodies validated by
the Human Protein Atlas project in numerous tissues including
the skeletal muscle (www.proteinatlas.org), the expected striated
pattern of Z-discs was found on 14-day post-natal mouse and
human foetal skeletal muscles (Fig. 9A,B). Our colocalization
experiments revealed substantial, although not complete, overlap
of PP1c with Gemin8. These results support the conclusion that
Gemin8 and PP1c could colocalize in vivo.
Our previous studies showed a marked reduction of SMN
levels in skeletal muscles from foetuses with severe SMA (Burlet
et al., 1998) (Fig. 9D). Morphological defects consistent with a
Z-disc deficiency have been reported in a mouse model with
severe SMA (Walker et al., 2008; Kariya et al., 2008). To address
Fig. 6. Depletion of PP1c enhances
localization of components of the SMN
complex and snRNPs in CBs. Double-
immunofluorescence analyses of HeLa cells
transfected with control scrambled or PP1c
siRNA using antibodies against (A) PP1c,
(B) SMN-complex component Gemin3,
(C) Gemin8, (D) TMG-capped snRNA,
(E) SmD3 core protein and (F) U1-specific
70 kDa protein (green) and co-stained for
DNA (DAPI) or the CB marker coilin (red).
The yellow in merge indicates overlapping
signals. Scale bars: 3 mm.
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the question of whether similar defects occur in the human
disease, colocalization experiments were carried out on muscle
sections from SMA foetuses (Fig. 9C). An altered organization of
the striated pattern was observed as indicated by aberrant Gemin8
and PP1c localization and a severe atrophy, reflecting denervated
fibers. To provide molecular insights into pathobiology, control
and severe SMA fibroblast cell extracts were immunoprecipitated
using anti-Gemin8 antibodies and co-immunoprecipitated
proteins were analysed by immunoblotting (Fig. 9E). As
reported previously (Lefebvre et al., 2002), a reduction of SMN
levels of ,75% was detected in SMA fibroblast cell cultures
compared with control fibroblasts. There was a significant
(P,0.01) 60% reduction in interaction between SMN and
Gemin8 or PP1c in SMA fibroblasts, whereas no significant
difference of the Gemin8 interaction with PP1c was detected
(Fig. 9F). This is consistent with the 50–70% reduction of in vitro
snRNP assembly activity previously reported for SMA fibroblast
cell extracts (Gabanella et al., 2007; Wan et al., 2005). Our
results support the conclusion that the production of SMN
complex is less efficient in SMA conditions.
Discussion
The SMN complex plays a central role in snRNPs biogenesis
(Fischer et al., 1997) and in SMA, the second most frequent
autosomal recessive disease of children (Lefebvre et al., 1995).
snRNP biogenesis is fundamental for splicing and transcriptome
integrity (Kaida et al., 2010). One key consequence of splicing
activity in cells is the accumulation of SMN and snRNPs in CBs
(Liu and Dreyfuss, 1996; Carvahlo et al., 1999), which is
disrupted in SMA motor neurones (Lefebvre et al., 1997).
Understanding the mechanisms underlying SMN interaction is
important for cell survival in general and particularly for the
development of SMA therapy. Using co-immunoprecipitation
experiments we identified a previously unknown regulator of the
SMN complex. Protein phosphatase PP1c interacts with the
complex and regulates its formation and localization to CBs.
Fig. 7. Depletion of PP1c enhances CB
accumulation and the post-translational
modification status of SMN. Triple-labelling
immunofluorescence experiments were performed
with anti-PP1c, anti-SMN and anti-coilin antibodies
on HeLa cells transfected with (A) negative control
Gl2 (GL2) or (B) PP1c siRNA#5. (C) The PP1c-
silenced cells were transfected with FP–PP1c or
(D) FP alone. The arrowheads and arrows point to one
of the nuclear body gem (SMN alone) and to one of
the CBs (SMN and coilin), respectively. The
microscope was focused on the nuclear foci. Scale
bar: 3 mm. (E) Statistical analyses of SMN nuclear
bodies in silenced cells. Error bars indicate the s.e.m.;
***P,0.001 (Student’s t-test). (F) HeLa cells were
transfected with negative control (control RNAi) or
PP1c siRNA (PP1c RNAi). Cell lysates were analysed
by immunoblotting with PP1c, PP1a and SMN
antibodies. The anti-a-tubulin incubation served as a
loading control. (G) Nuclei preparations from cells
analysed in F were separated by conventional 2D gel
electrophoresis (IF; followed by second dimension,
SDS-PAGE). Immunoblots were revealed with anti-
SMN antibody. Brackets indicate four sections with
major changes upon PP1c knockdown and rescue. The
highest to the lowest phosphorylated forms of SMN
are from section 1 to 4. The arrowheads point to
isoforms accumulated in PP1c-depleted nuclei that
disappeared when FP–PP1c was expressed. The
arrows point to isoforms absent in PP1c-depleted
nuclei and restored in rescue experiments. (H) The
relative intensities of signals detected in sections of
the SMN immunoblots shown in G.
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Gemin8 binds directly to PP1c and brings it into the
multiprotein SMN complex, which is essential for snRNP
biogenesis. SMN complex subunits associate in a stepwise
manner in the cytoplasm at various stages of the snRNP
biogenesis pathway (Carissimi et al., 2006; Massenet et al.,
2002; Yong et al., 2010). Direct Gemin8 binding to SMN is at the
heart of the association of SMN–Gemin2 and Gemin6–Gemin7–
Gemin8–unrip subunits to form an intermediate complex that is
competent to associate the Sm proteins of snRNPs. Thereafter,
Gemin5, bound to the pre-snRNA, and Gemin3 and -4 are
considered to separately join the intermediate complex. We
observed here that the reduction of PP1c levels enhances SMN
interaction with Gemin8 and the number of CBs. As suggested by
a mathematical model predicting that CBs accelerate snRNP
biogenesis (Klingauf et al., 2006), our data indicate that PP1c
depletion enhances the cytoplasmic assembly of snRNPs and
thus, their nuclear import and accumulation in CBs.
Our observations suggest that the formation of an intermediate
complex made of SMN–Gemin2 and Gemin6–Gemin7–Gemin8–
unrip is regulated by phosphorylation. We propose that PP1c
regulates the phosphorylation state of SMN to prevent premature
formation of the intermediate complex. Although the exact PP1c
target sites of SMN are unknown, 2D-gel analyses reveal that
lowering PP1c levels lead to accumulation of hyperphosphorylated
SMN (Fig. 7). Moreover, a reduction in the extent of SMN
phosphorylation was observed by expressing PP1c in PP1c-
depleted cells, which correlates with a lower CB number,
reflecting downregulation of snRNP biogenesis. This provides a
link between previous studies showing that SMN complex
formation depends on SMN phosphorylation (Grimmler et al.,
2004; Burnett et al., 2009) and its interaction with Gemin8
(Carissimi et al., 2006).
Other studies involving dephosphorylation of SMN in the
nucleoplasm, showed that PP1MG regulates SMN complex
stability in CBs (Petri et al., 2007). Consistent with our findings,
PP1MG activity is probably not altered in PP1c-depleted cells.
The Gemin8 interaction with PP1c in CBs (Fig. 2E) suggests
that the two phosphatases function in different subnuclear
compartments. Although SMN is the best candidate for a PP1c
substrate, other proteins interacting with Gemin8 or located in the
vicinity could also be candidates. There are sixteen potential
phosphoserines in SMN. It will be interesting to determine
whether PP1c targets the same residues as PP1MG and if not, this
could explain why depletion of PP1MG decreases SMN
localization to CBs (Petri et al., 2007), whereas PP1c depletion
increases it.
Regulation of SMN interactions could stabilize the complex
(Burnett et al., 2009; Ogawa et al., 2009). SMA mutations in the
C-terminal region prevent self-oligomerization (Lorson et al.,
1998) that disrupts Gemin8 binding to SMN and hinder SMN
complex formation (Otter et al., 2007). There is a second minor
self-oligomerization domain lying in the Lys-rich domain
of SMN (Morse et al., 2007). Indeed, PP1c interaction with
SMN complex appears to require two elements, the self-
oligomerization Lys-rich domain of SMN (Fig. 1) and Gemin8
(Fig. 2). Dependence on the production of a functional SMN
complex would provide a rationale for the failure of PP1c to
associate with a mutant lacking the self-oligomerization
domains. Another possibility is that the phosphoserine S80-P
(MS information, PhosphositePlus; http://www.phosphosite.org/)
located within the Lys-rich domain might be sensitive to PP1c.
This aspect awaits further investigation.
It is worth noting that SMA modelling in Drosophila
melanogaster and Caenorhabditis elegans has identified PP1
regulatory (inhibitory) subunit 13B (PP1R13B) as a modifier of
SMN-deficiency phenotypes (Chang et al., 2008; Dimitriadi et al.,
2010). This is consistent with our model in which ablation of the
PP1 regulatory subunit exacerbates SMN-related defects by
upregulating PP1. Only SMN and Gemins2, -3 and -5 has been
identified in Drosophila (Kroiss et al., 2009). It is therefore
conceivable that another SMN-associated protein binds PP1c. In
Fig. 8. Depletion of PP1c promotes formation of the SMN complex.
(A) HeLa cells were transfected with control Gl2 or three different PP1c
siRNAs (#5, #6 and #8) and separated into cytosolic and nuclear fractions.
The fractions were analysed by immunoblotting with antibodies against
components of the SMN complex. The anti-a-tubulin and anti-HDAC
incubations served as loading controls for the cytosolic and nuclear fractions,
respectively. (B) The cytosolic fractions of HeLa cells transfected with Gl2 or
PP1c siRNA #5 were immunoprecipitated with control mouse
immunoglobulins (Ctrl) and anti-SMN antibody (SMN). The
immunoprecipitates were analysed by immunoblotting. (C) The relative
amounts of the proteins associated with SMN were estimated using the
relative band intensities detected by immunoblotting, normalized to the SMN
band. The histograms show the results of five experiments. Error bars indicate
the s.e.m. *P,0.042 (Wilcoxon signed-rank test). (D) Similar analyses of the
SMN complex in the nucleus.
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the human SMN complex, Gemin5 has a putative PP1-binding
RVxF motif, but Gemin5 does not form CBs (Hao et al., 2007).
Other PP1-binding motifs are Fxx[R/K]x[R/K] (Garcia et al.,
2004) and DxxDxxxD (Neduva et al., 2005). The former motif
occurs in Gemin4 and the latter in SMN. We have shown here
that neither Gemin4 nor SMN recruits PP1c to CBs (Fig. 3).
Collectively, our results are most consistent with Gemin8
targeting PP1c to CBs. The similarity of effects upon Gemin8
overexpression (Fig. 4) and PP1c depletion (Fig. 6) indicate that
Gemin8 is a previously unknown regulatory subunit of PP1.
Loss of SMN leads to motor neuron degeneration and muscle
atrophy in SMA. The importance of SMN in muscles is
beginning to be appreciated, given the varing degrees of
disease severity (Bosch-Marce´ et al., 2011; Kariya et al., 2008;
Mutsaers et al., 2011). Although the mechanisms are still elusive,
several observations can be considered. Lowering SMN in
cultured cells alters fusion and morphology of differentiated
myoblasts (Shafey et al., 2005). Ablation of the muscular SMN
causes loss of regeneration by satellite cells (Nicole et al., 2003).
Moreover, localization of the SMN complex with a-actinin at the
level of Z-discs suggests a function outside snRNP biogenesis
(Walker et al., 2008). Our observations that PP1c and Gemin8
colocalize at Z-discs indicate that PP1c could regulate a function
of the SMN complex in vivo (Fig. 9). Lack of subcellular
organization and aberrant localization of Gemin8 and PP1c, as
observed in SMA muscles, compares well with the Z-disc
phenotype in SMA mouse models (Walker et al., 2008). Another
interesting observation is that the interaction of PP1c with SMN
is reduced in SMA cells. These defects might impair the
regulation of SMN complex in SMA.
A plausible strategy for the development of therapeutics for
SMA is to increase SMN protein levels (Lorson et al., 2010). The
physiological relevance of our data is that a specific manipulation
of PP1c might impact on the SMN complex independently of an
increase in SMN levels (Figs 5, 8). However, pharmacological
ablation of all three PP1 catalytic subunits causes formation of
SMN nuclear gems in SMA cells (Novoyatleva et al., 2008; our
unpublished data). Because gems are storage sites formed when
pre-mRNA splicing is inhibited, more specific molecules will be
required. Modeling the interaction shown here between PP1c and
the SMN complex could be a promising target in SMA therapy.
Future in vivo experiments will need to address whether this has
any beneficial effects.
Remarkable pleiotropy is seen for PP1 holoenzymes in distinct
cellular pathways, including the EGF, TGF-b and FGF signaling
pathways that have been linked to SMN (Bruns et al., 2009;
Chang et al., 2008; Gangwani et al., 2001; Sen et al., 2011). Our
studies reveal a regulation of the SMN complex and of nuclear
body formation by PP1c, identify Gemin8 as directly interacting
with PP1c, show mislocalization of PP1c and Gemin8 in SMA
muscles in vivo and altered interaction of PP1c with SMN in
SMA cells. A tight regulation of SMN complex assembly is
revealed. It is therefore possible that imbalance of SMN sub-
complexes produced by the reduction of SMN contributes to
SMA severity.
Materials and Methods
Cell culture and transfections
COS7 and HeLa cell cultures were maintained in DMEM supplemented with 10%
FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml) in a humidified CO2
incubator at 37 C˚. HeLa cells were plated in 60 mm dishes or eight-chamber
culture slides (Becton Dickinson) for transfection using HiPerFect transfection
reagent (Quiagen) with PP1c-validated siRNAs (Hs_PPP1CC_5, _6 and _8) and
negative controls Gl2 or scrambled duplexes (25 nM). For the rescue experiments,
HeLa cells were first transfected with siRNA (Hs_PPP1CC_5) and 16 hours
later the cells were transfected with pdEYFP-PP1c plasmid (IOH14587-
pdEYFPC1amp, imagines, Source BioScience, Nottingham, UK) using
Transmessenger reagent (Qiagen). After a 5-hour incubation, the medium was
Fig. 9. Localization of Gemin8 and PP1c in skeletal muscles.
(A,B) Subcellular localization of Gemin8 and PP1c in
longitudinal mouse and human foetal skeletal muscle sections as
shown by immunofluorescence. Gemin8 has the striated
appearance of the Z-discs as previously described for the
components of the SMN complex (Walker et al., 2008). PP1c
colocalizes with Gemin8 at the Z-discs as shown in merged
images (yellow). ‘2nd only’ are control images of muscle
sections incubated with the two fluorescent secondary antibodies
alone. (C) SMN deficiency altered the muscle structure
organization and localization of Gemin8 and PP1c in human
Type I SMA foetuses. (D) Immunoblot analyses of muscle
lysates from human control and type I SMA foetuses with
Gemin8, SMN and PP1c. The anti-a-tubulin incubation served as
loading control. (E) Immunoprecipitation of Gemin8 from
control and type I SMA patient fibroblasts were analysed by
immunoblotting. (F) Statistical analyses of the relative levels of
SMN and PP1c co-precipitated with anti-Gemin8 antibody, and
normalized to the levels of immunoprecipitated Gemin8 and to
the levels of SMN input in samples (n53). Error bars indicate
s.e.m.; **P,0.01 (Student’s t-test).
PP1 regulation of SMN complex 2871
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
replaced with fresh medium and incubated for a further 21 hours. Using FuGENE
(Roche), HeLa cells were transfected with expression plasmids for pEGFP-SMN
(Renvoise´ et al., 2006), myc-Gemin4 (a gift from S. Massenet, CNRS, Nancy)
and pdEYFP-Gemin8 (IOH3877-pdEYFP-C1amp; imaGenes), and pdEYFP-
Gemin8DC or pdEYFP-Gemin8DC3A.
Indirect immunofluorescence
Forty-two hours post-transfection with siRNAs or 21 hours with DNA plasmids,
HeLa cells were prepared for indirect immunofluorescence microscopy as
described previously (Renvoise´ et al., 2006). Briefly, transfected cells were
fixed in 4% formaldehyde, permeabilized with 0.5% Triton X-100 and incubated
with the following antibodies (polyclonal unless otherwise designated as
monoclonal: mAb): anti-SMN at 1:1000, mouse mAb 4B3 (Burlet et al., 1998)
or 2B1 from Transduction Laboratories, anti-coilin [mouse mAb at 1:1000
(Transduction Laboratories) or rabbit at 1:1000 (Santa Cruz)], anti-PP1c (goat at
1:1000, SC), anti-Gemin3 (mouse mAb at 1:250; Abcam), anti-Gemin8 (rabbit at
1:30; Sigma), anti-TMG (mouse mAb at 1:4000; Calbiochem), anti-SmD3 protein
(rabbit at 1:100; Sigma), anti-U1-specific 70 kDa protein (rabbit at 1:500; Aviva),
anti-SC35 (mouse mAb at 1:1000; Sigma), anti-myc (mouse mAb at 1:1000;
Covance) and either Cy3 or Cy5 (1:400; Jackson Laboratories) or Alexa-Fluor-
488-conjugated secondary antibodies (1:400; Invitrogen). The final wash
contained 0.1 mg/ml 4, 6-diamidino-2-phenylindole (DAPI; Molecular probes) to
stain DNA. Cryosections (7–10 mm) of muscle tissues from mouse (provided by J.
Cartaud) and human foetuses frozen at –80 C˚ in isopentane were mounted for
immunostaining as described previously (Lefebvre et al., 1997; Burlet et al., 1998).
In situ proximity ligation assay
In situ proximity ligation assay (PLA) was performed as recommended by the
manufacturer (DuolinkII kit, Olink Bioscience AB). Briefly, HeLa cells were fixed
and permeabilized as above. Primary antibodies were diluted at 1.75 ng/ml rabbit
anti-Gemin8 (Atlas antibodies, Sigma) and 2 ng/ml goat anti-PP1c (C19, SC) in 16
antibody diluent and incubated for 30 minutes at room temperature. The negative
control consisted of using only one primary antibody. The cells were washed twice
for 5 minutes in Tris-buffered saline with 0.05% Tween. The PLA probes (Rabbit-
MINUS and Goat-PLUS; Olink BioScience AB) were incubated for 90 minutes at
37 C˚. Subsequent steps were performed using the detection reagent Orange
according to the DuolinkII kit protocol. In situ PLA signals were visible as dots
with the RITC filter on the microscope. Nuclei were counterstained with DAPI to
be able to select image position.
Image acquisition and manipulation
Immunofluorescence signals were observed by nonconfocal microscopy (Leica
DMR, objective 636/1.32). Black and white images were acquired with a cooled
CCD camera (Micromax, Princetown Instruments, Inc.) using the MetaView
Imaging System. Figures were processed and assembled with Photoshop (Adobe).
Protein extract preparation and immunoprecipitation
Cytosolic and nuclear fractionation was performed with a NE-PER kit (Pierce). For
immunoprecipitations, the cytosolic fractions were used directly and isolated
nuclei or frozen cell pellets were resuspended in immunoprecipitation (or RIPA)
buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP40, EDTA-free protease
inhibitors cocktail (Roche)], passed through a 27-gauge needle and clarified by
centrifugation at 15,000 g for 15 minutes at 4 C˚. Protein G dynabeads (25 ml;
Invitrogen) were covalently bound to 10 mg of the following antibodies according
to the manufacturer’s protocol: mouse monoclonal anti-GFP (Roche), mouse
monoclonal anti-SMN 4B3 or mouse negative control antibodies (DAKO). The
coated dynabeads were incubated with protein extracts for 1 hour at 4 C˚. After five
to seven washes in 1 ml immunoprecipitation buffer, the bound proteins were
eluted by boiling in 26SDS sample buffer and resolved by SDS-PAGE. Cultured
COS cells expressing either GFP–SMN or GFP–N86M2 were crosslinked with
dithiobis[succinimidyl propionate] (Pierce) to facilitate the biochemical analysis
for Fig. 1E only. The anti-Gemin8 immunoprecipitations were performed in IP
buffer containing 0.01% SDS using rabbit anti-Gemin8 antibodies (Santa Cruz)
and negative control rabbit antibodies (DAKO).
Protein expression and purification
His-tagged PP1c was expressed from IOH14587-pDEST17-D18 (imaGenes) in E.
coli BL21 (DE3) pLysS (Stratagene) at 30 C˚ for 5 hours and purified on Ni-NTA
agarose (Qiagen) as previously described for His-tagged proteins (Lefebvre et al.,
2002). Purified His–PP1c was either used immediately or snap-frozen and kept
at 280 C˚. GST vector (Pharmacia) and GST–Gemin8 (IOH3877-pDEST15,
imaGenes) were expressed in E. coli Rosetta2 (DE3) pLysS (Novagen, Merck) at
room temperature for 5 hours. Recombinant GST proteins were purified and
retained on magnetic beads (magneGST protein purification system, Promega) for
protein-binding assays, or eluted by boiling in 26SDS sample buffer and resolved
by SDS-PAGE.
In vitro protein-binding assay
SMN complex was immunopurified from HeLa whole-cell extracts with
monoclonal antibody 4B3 under stringent conditions (500 mM NaCl and 0.1%
NP40) on magnetic dynabeads as described above. The immobilized proteins
(SMN complex or GST proteins, 12.5 ml of magnetic beads slurry) were pre-
incubated for 5 minutes with 1 mg/ml BSA, washed and incubated for 30–
60 minutes at 4 C˚ with 2.5 mg of purified recombinant His-tagged PP1c in 25 ml of
binding buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5 mM
MnCl2, 1 mM dithiothreitol (DTT) and 0.05% NP40. The bound proteins were
washed five to seven times with 500 ml of ice-cold binding buffer and eluted by
boiling in 26 SDS sample buffer.
Protein separation and immunoblot analysis
Protein samples were separated by 11% SDS-PAGE (Prosieve acrylamide) or a 4–
12% gradient (Invitrogen) and electrotransferred to PVDF membranes (Millipore).
Immunoblotting was performed as described previously (Renvoise´ et al., 2006),
revealed by chemiluminescence (ECL; GE Healthcare) and exposed to Fuji high-
speed X-ray films or captured with a Fujifilm LSA-3000 camera system. The
following antibodies were used: anti-SMN (mouse mAb 4B3 at 1:5000), anti-
Gemin2 and -3 (mouse mAb at 1:500; Abcam), Gemin4 (goat at 1:4000; Santa
Cruz), Gemin8 (mouse mAb at 1:1000; Abcam), PP1a (rabbit at 1:10,000; Santa
Cruz), PP1c (goat at 1:10,000; Santa Cruz), a-tubulin (mouse mAb at 1:10,000;
Sigma), HDAC (rabbit at 1:500; Santa Cruz), phosphoserine (rabbit at 1:200;
Invitrogen), GFP (mouse at 1:1000; Roche; or rabbit at 1:5000; Abcam) and
horseradish peroxidase-conjugated IgG (at 1:10,000; GE Healthcare or Santa
Cruz). For 2D-gel electrophoresis, the nuclear pellets prepared using the NE-PER
kit were directly solubilized in 8 M urea, 1 M thiourea, 2.5% CHAPS, 23 mM
DTT and 0.5% immobilized pH gradient (IPG) using a 27-gauge needle. The first-
dimension was performed in strips with IPG using pH 3–10 linear IPG drystrips
(GE Healthcare) at the Institut Jacques Monod proteomics facility.
Statistical analyses of ECL signals were performed with ImageJ using grayscale
images generated with an Epson Perfection 4990 PHOTO transparency scanner
(1000 d.p.i. images, as shown in the figures assembled with Photoshop) or with a
luminescent analyser LAS-3000 camera system (Fujifilm).
Candidate proteins by mass spectroscopy
Co-immunopurified proteins were separated by SDS-PAGE and visualized by
mass-spectrometry-compatible silver staining (Silver Quest, Invitrogen). The
bands of interest were excised, extensively digested with trypsin, and extracted
peptides were analysed using a-cyano-4-hydroxycinnamic acid (CHCA) matrix on
a 4800 TOF-TOF mass spectrometer (Applied Biosystems) equipped with a YAG-
200 Hz laser (355 nm) at Institut Jacques-Monod proteomics facility. Protein
identification presented in supplementary material Fig. S1 was performed using
expasy proteomics tools (www.expasy.org/tools/).
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Fig. S1. Identication of the 40 kDa protein associated with the N-terminal region of SMN. (A) Protein iden-
tication was made with the Mascot search soware using the peptides derived from a trypsin digestion of the 
40 kDa band. Peptide coverage map for the protein phosphatase catalytic subunit PP1γ revealed 73% coverage, 
including the N- and C-terminal ends. (B) Profound search also showed the candidate to be PP1γ.
